Global Drug of Abuse (DOA) Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI02244256

Publication Date:

February 16, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Drug of Abuse (DOA) Testing market size was valued at US$ 6183.5 million in 2023. With growing demand in downstream market, the Drug of Abuse (DOA) Testing is forecast to a readjusted size of US$ 9964.6 million by 2030 with a CAGR of 7.1% during review period.
The research report highlights the growth potential of the global Drug of Abuse (DOA) Testing market. Drug of Abuse (DOA) Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug of Abuse (DOA) Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug of Abuse (DOA) Testing market.
The drug of abuse test is听an immunoassay based on the principle of competitive binding.听
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Key Features:
The report on Drug of Abuse (DOA) Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Drug of Abuse (DOA) Testing market. It may include historical data, market segmentation by Type (e.g., Urine, Saliva), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug of Abuse (DOA) Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug of Abuse (DOA) Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug of Abuse (DOA) Testing industry. This include advancements in Drug of Abuse (DOA) Testing technology, Drug of Abuse (DOA) Testing new entrants, Drug of Abuse (DOA) Testing new investment, and other innovations that are shaping the future of Drug of Abuse (DOA) Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug of Abuse (DOA) Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Drug of Abuse (DOA) Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug of Abuse (DOA) Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug of Abuse (DOA) Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug of Abuse (DOA) Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug of Abuse (DOA) Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug of Abuse (DOA) Testing market.
Market Segmentation:
Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Urine
Saliva
Hair
Others
Segmentation by application
Hospitals
Laboratories
Workplace
At-Home
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug of Abuse (DOA) Testing Market Size 2019-2030
2.1.2 Drug of Abuse (DOA) Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug of Abuse (DOA) Testing Segment by Type
2.2.1 Urine
2.2.2 Saliva
2.2.3 Hair
2.2.4 Others
2.3 Drug of Abuse (DOA) Testing Market Size by Type
2.3.1 Drug of Abuse (DOA) Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug of Abuse (DOA) Testing Market Size Market Share by Type (2019-2024)
2.4 Drug of Abuse (DOA) Testing Segment by Application
2.4.1 Hospitals
2.4.2 Laboratories
2.4.3 Workplace
2.4.4 At-Home
2.4.5 Others
2.5 Drug of Abuse (DOA) Testing Market Size by Application
2.5.1 Drug of Abuse (DOA) Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug of Abuse (DOA) Testing Market Size Market Share by Application (2019-2024)
3 Drug of Abuse (DOA) Testing Market Size by Player
3.1 Drug of Abuse (DOA) Testing Market Size Market Share by Players
3.1.1 Global Drug of Abuse (DOA) Testing Revenue by Players (2019-2024)
3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Drug of Abuse (DOA) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug of Abuse (DOA) Testing by Regions
4.1 Drug of Abuse (DOA) Testing Market Size by Regions (2019-2024)
4.2 Americas Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
4.3 APAC Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
4.4 Europe Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
5.2 Americas Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
5.3 Americas Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug of Abuse (DOA) Testing Market Size by Region (2019-2024)
6.2 APAC Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
6.3 APAC Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing by Country (2019-2024)
7.2 Europe Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug of Abuse (DOA) Testing by Region (2019-2024)
8.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug of Abuse (DOA) Testing Market Forecast
10.1 Global Drug of Abuse (DOA) Testing Forecast by Regions (2025-2030)
10.1.1 Global Drug of Abuse (DOA) Testing Forecast by Regions (2025-2030)
10.1.2 Americas Drug of Abuse (DOA) Testing Forecast
10.1.3 APAC Drug of Abuse (DOA) Testing Forecast
10.1.4 Europe Drug of Abuse (DOA) Testing Forecast
10.1.5 Middle East & Africa Drug of Abuse (DOA) Testing Forecast
10.2 Americas Drug of Abuse (DOA) Testing Forecast by Country (2025-2030)
10.2.1 United States Drug of Abuse (DOA) Testing Market Forecast
10.2.2 Canada Drug of Abuse (DOA) Testing Market Forecast
10.2.3 Mexico Drug of Abuse (DOA) Testing Market Forecast
10.2.4 Brazil Drug of Abuse (DOA) Testing Market Forecast
10.3 APAC Drug of Abuse (DOA) Testing Forecast by Region (2025-2030)
10.3.1 China Drug of Abuse (DOA) Testing Market Forecast
10.3.2 Japan Drug of Abuse (DOA) Testing Market Forecast
10.3.3 Korea Drug of Abuse (DOA) Testing Market Forecast
10.3.4 Southeast Asia Drug of Abuse (DOA) Testing Market Forecast
10.3.5 India Drug of Abuse (DOA) Testing Market Forecast
10.3.6 Australia Drug of Abuse (DOA) Testing Market Forecast
10.4 Europe Drug of Abuse (DOA) Testing Forecast by Country (2025-2030)
10.4.1 Germany Drug of Abuse (DOA) Testing Market Forecast
10.4.2 France Drug of Abuse (DOA) Testing Market Forecast
10.4.3 UK Drug of Abuse (DOA) Testing Market Forecast
10.4.4 Italy Drug of Abuse (DOA) Testing Market Forecast
10.4.5 Russia Drug of Abuse (DOA) Testing Market Forecast
10.5 Middle East & Africa Drug of Abuse (DOA) Testing Forecast by Region (2025-2030)
10.5.1 Egypt Drug of Abuse (DOA) Testing Market Forecast
10.5.2 South Africa Drug of Abuse (DOA) Testing Market Forecast
10.5.3 Israel Drug of Abuse (DOA) Testing Market Forecast
10.5.4 Turkey Drug of Abuse (DOA) Testing Market Forecast
10.5.5 GCC Countries Drug of Abuse (DOA) Testing Market Forecast
10.6 Global Drug of Abuse (DOA) Testing Forecast by Type (2025-2030)
10.7 Global Drug of Abuse (DOA) Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Siemens
11.1.1 Siemens Company Information
11.1.2 Siemens Drug of Abuse (DOA) Testing Product Offered
11.1.3 Siemens Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Siemens Main Business Overview
11.1.5 Siemens Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Drug of Abuse (DOA) Testing Product Offered
11.2.3 Merck Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Drug of Abuse (DOA) Testing Product Offered
11.3.3 Roche Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product Offered
11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Information
11.5.2 Bio-Rad Drug of Abuse (DOA) Testing Product Offered
11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bio-Rad Main Business Overview
11.5.5 Bio-Rad Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott Drug of Abuse (DOA) Testing Product Offered
11.6.3 Abbott Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Information
11.7.2 Quest Diagnostics Drug of Abuse (DOA) Testing Product Offered
11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Quest Diagnostics Main Business Overview
11.7.5 Quest Diagnostics Latest Developments
11.8 Psychemedics
11.8.1 Psychemedics Company Information
11.8.2 Psychemedics Drug of Abuse (DOA) Testing Product Offered
11.8.3 Psychemedics Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Psychemedics Main Business Overview
11.8.5 Psychemedics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂